M
Maicon Falavigna
Researcher at Universidade Federal do Rio Grande do Sul
Publications - 108
Citations - 6354
Maicon Falavigna is an academic researcher from Universidade Federal do Rio Grande do Sul. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 27, co-authored 89 publications receiving 4227 citations. Previous affiliations of Maicon Falavigna include McMaster University & Pontifícia Universidade Católica do Rio Grande do Sul.
Papers
More filters
Journal ArticleDOI
Rótulos de medicamentos na perspectiva dos profissionais de saúde brasileiros: dificuldades, nível de satisfação e melhorias propostas
Cassia Garcia Moraes,Tatiane S. DAL PIZZOL,Maicon Falavigna,Lisana Reginini Sirtori,Fernanda Silva Cruz,Guilherme Webster,Emilia da Silva Pons +6 more
TL;DR: For instance, in a study of 1.056 técnicos of enfermagem, enfermeiros, and farmacêuticos in 10 capitais brasileiras as discussed by the authors , a maioria of the participants found it difficult or muito difícil to distinguish between frascos idênticos (82,4%), rótulos semelhantes (82.5%), and different doses of the same medication, and embalagens with different doses.
Journal ArticleDOI
EE9 Cost-Effectiveness Analysis of Dupilumab, Mepolizumab and Benralizumab for Severe Eosinophilic Asthma With Blood Eosinophil Count ≥300 Cells/Mcl in the Brazilian Private Healthcare Perspective
A. Taminato,Alba Kyonara Barbosa,Fjb Magro,Paolo Federico,Rnt Prioli,Suely Goldflus,CB Migliavaca,Maicon Falavigna +7 more
TL;DR: In this paper , the authors compared the cost effectiveness of dupilumab, mepolizumab and benralizumaab for the treatment of patients with severe eosinophilic asthma using ICS-LABA with baseline blood EOSINophil count ≥ 300 cells/mcl and three or more episodes of asthma exacerbation.
Journal ArticleDOI
Knowledge mobilization activities to support decision-making by youth, parents, and adults using a systematic and living map of evidence and recommendations on COVID-19: protocol for three randomized controlled trials and qualitative user-experience studies
Rana Charide,Lisa Stallwood,Matthew Munan,S. Sayfi,Lisa Hartling,Nancy J. Butcher,Martin Offringa,Sarah A. Elliott,Dawn Richards,Joseph L. Mathew,Elie A. Akl,Tamara Kredo,Lawrence Mbuagbaw,A. Motillal,Ami Baba,Matthew J. Prebeg,Jacqueline Relihan,Shannon D. Scott,Jozef Suvada,Maicon Falavigna,Miloslav Klugar,Tamara Lotfi,Adrienne Stevens,Kevin Pottie,Holger J. Schünemann +24 more
TL;DR: In this article , the authors evaluate, quantify, and compare the public's understanding, usability, satisfaction, intention to implement, and preference for different ways of presenting COVID-19 health recommendations derived from the Living Map of Recommendations and Gateway to Contextualization (RecMap).
Journal ArticleDOI
Teaming-up nurses with ophthalmologists to expand the reach of eye care in a middle-income country: Validation of health data acquisition by nursing staff in a telemedicine strategy.
Cassia Garcia Moraes Pagano,Taís de Campos Moreira,Daniel Sganzerla,Ana Maria Frölich Matzenbacher,Amanda Gomes Faria,Lucas Matturro,Felipe Cezar Cabral,Dimitris Rucks Varvaki Rados,Anelise Decavata Szortyka,Maicon Falavigna,Maria Eulália Vinadé Chagas,Erno Harzheim,Marcelo Rodrigues Gonçalves,Roberto Nunes Umpierre,Aline Lutz de Araujo,Aline Lutz de Araujo +15 more
TL;DR: In this article, a cross-sectional study was conducted with 140 patients referred to an ophthalmological telediagnosis center by primary healthcare doctors, where the health parameters evaluated were visual acuity (VA), objective ophthalmic measures acquired by autorefraction, keratometry and intraocular pressure (IOP).
Journal ArticleDOI
PP117 Isosorbide And Nifedipine In Chagas Patients: A Systematic Review
Celina Borges Migliavaca,Cinara Stein,Verônica Colpani,Sandro Miguel,Maicon Falavigna,Luciane Nascimento Cruz +5 more
TL;DR: The available evidence shows isosorbide is effective in the management of gastrointestinal symptoms and can be aggregated to clinical guidelines, having an important value to inform general practitioners on the decision-making process regarding treatment of this group of patients.